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Introduction
The prognosis of dialysis patients is still rather poor
compared with the general population, with the expected
remaining life span of a patient starting dialysis only
one quarter that of a similar aged person in the gen-
eral population. In this context, the quantification of the
administered dialysis dose is an essential element in
the management of chronic hemodialysis patients be-
cause many studies have shown that morbidity and mor-
tality of these patients are significantly related to the dose
of delivered dialysis. The National Cooperative Dialysis
Study (NCDS) was the first multicenter randomized clin-
ical trial to evaluate the impact of hemodialysis dose in
terms of small and middle molecule removal on patients’
clinical outcome, and found that those patients who had
been randomized to achieve higher time-averaged urea
concentrations displayed a significantly higher rate of
withdrawal from dialysis because of death or clinical
problems. Subsequently, the Kt/V formula was proposed
by Gotch and Sargent as a method to determine the dial-
ysis dose, where K is the “effective” dialyzer urea clear-
ance, t is the duration of the session, and V is the urea
distribution volume. It has become the most useful and
widely applied index to prescribe the dialysis dose, as well
as to assess the dose that is actually delivered. The appli-
cation of the Kt/V index in the secondary, so-called mech-
anistic analysis of the NCDS results performed by Gotch
showed the existence of a step relationship between Kt/V
values and patient survival. The analysis showed a 53%
failure rate at all Kt/V values less than 0.90, and a sharp
decrease in failure to about 13% at Kt/V levels greater
than 1.0. Another retrospective analysis of the NCDS by
Keshaviah suggested the existence of a continuous expo-
nential relationship between the probability of dialysis
failure and Kt/V values, also finding a clinical benefit for
Kt/V higher than 1.2. In the years that followed, several
observational studies found a linear decrease in mortal-
ity, with Kt/V values as high as 1.6. In contrast to these
observational studies, the HEMO Study, which is the
only prospective randomized clinical trial on the clinical
impact of hemodialysis dose to be performed since the
NCDS, did not find any improvement, either in survival
or in the rate of hospitalization in those patients random-
ized to a higher dialysis dose (Kt/V 1.65) compared with
those randomized to a more conventional dialysis dose
(Kt/V 1.25). However, the 4% reduction in mortality ob-
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served with higher doses in the HEMO Study, although
not statistically significant, may be very significant from a
clinical point of view, suggesting the possibility of clinical
benefit from delivering dialysis doses that are at least as
high as those obtained in the control group of patients of
the HEMO Study.
Nevertheless, one major problem encountered in clin-
ical practice is that very often a large difference exists
between the prescribed and the delivered dialysis dose,
thus making it essential to find a reliable, easy, noninva-
sive, and inexpensive means of determining Kt/V during
the routine monitoring of delivered dialysis. At present,
the “gold standard” for the determination of Kt/V is di-
rect dialysis quantification (DDQ), which provides the
most reliable calculation of V and K. Unfortunately, this
method requires total dialysate collection and three BUN
values (predialysis, post dialysis, and an equilibrated post-
dialysis sample), and therefore, is not easily applicable to
the everyday clinical practice. Therefore, blood-side Kt/V
is currently determined using the single-pool variable vol-
ume urea kinetic model or derived simplified equations.
These methods are easier than the DDQ technique be-
cause they do not require delayed postdialysis blood sam-
pling and dialysate collection, but they still require at least
two blood samples before and after each treatment. As
a consequence, the quantification of the delivered dial-
ysis dose is performed only from time to time (usually
monthly), with the obvious risk that significant variations
in the delivered dose during different sessions may go un-
noticed. The V may reasonably be assumed to be constant
for prolonged periods of time in stable patients, but K may
be adversely affected by a number of factors not readily
apparent, such as blood and dialysate flows, fistula recir-
culation, and microclotting of the dialyzer. Consequently,
the ideal method for routine DDQ would be online mea-
surement of K at each individual dialysis session.
The existence of a very high correlation between
dialysate conductivity and its sodium content led to the
hypothesis that sodium dialysance can be estimated by
conductivity clearance (Kcn), which can be determined
simply by measuring the outlet dialysate conductivities at
two different values of inlet conductivity. With the knowl-
edge that the diffusion constants for NaCl and urea are
almost equal, and Na dialysance is therefore comparable
to urea clearance, the measurement of Kcn was proposed
for the on-line estimation of instant “effective” dialyzer
urea clearance. If the measurements of Kcn are frequent
enough for calculating a reliable estimation of its mean
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value during the whole session, and if the estimation of
urea clearance through Kcn is satisfactory, Kt/V can be
determined at each dialysis session, provided that V has
been adequately determined. However, to date, the re-
lationship between Kcn and urea clearance in published
studies has given conflicting results. In 1993, Petitclerc
et al showed that Kcn values were always lower than urea
clearance values measured by conventional method. A
subsequent study by the same authors showed the ex-
istence of a very good correlation between the deliv-
ered Kt/V, as measured by the DDQ method, and that
measured using the conductivity method. In contrast to
this, Manzoni et al found some discrepancies between
Kt/V based on Kcn when compared with DDQ studies.
Nevertheless, in the latter study, Kcn and urea clearance
proved to be strongly related, so that Kt/V could be de-
rived according to a regression equation. Subsequently,
according to the consideration that electrolytes are elec-
trically charged, but urea is not, it was hypothesized that
the discrepancy between urea clearance and Kcn could
be related to the dialyzer membrane, so the ionic trans-
fer across the dialyzer membrane, and thus the Kcn/K
value, could be influenced by the surface charge of the
membrane. However, in vitro data showing equivalence
between urea clearance and Kcn when using a neutral
membrane (polysulphone), and discrepancy when using
a charged membrane (cellulose acetate), were not sup-
ported by in vivo data, showing only a slight difference
between charged and uncharged membranes, and only at
very low urea clearance rates. More recently, Di Filippo
et al have suggested that the discrepancy between urea
clearance and Kcn can be caused by the effect of car-
diopulmonary recirculation on inlet plasma water con-
ductivity when inlet dialysate conductivity is changed,
thus suggesting that the operative modalities for deter-
mining Kcn should be planned to minimize such an effect
in order to obtain an adequate estimate of urea clearance.
Furthermore, equivalence between Kcn and “effective”
urea clearance has been reported in other studies. Despite
this, there is still not complete agreement as to the rela-
tionship between Kcn and urea clearance, and we strongly
believe that this work by Dr. Gotch and his colleagues will
give major new insights into the role of on-line monitor-
ing of dialysate conductivity to assure adequate delivery
of the dialysis dose. This methodology continues to be
a major area of research in hemodialysis because of the
role it plays in monitoring sodium balance and vascular
access flow, in addition to the delivered dose of dialysis.
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